177 related articles for article (PubMed ID: 9124865)
1. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
[TBL] [Abstract][Full Text] [Related]
2. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus viridans].
Gavaldà J; Pahissa A; Almirante B
Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):174-6. PubMed ID: 8011732
[No Abstract] [Full Text] [Related]
4. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
Martínez F; Martín-Luengo F; García A; Valdés M
Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.
Sexton DJ; Tenenbaum MJ; Wilson WR; Steckelberg JM; Tice AD; Gilbert D; Dismukes W; Drew RH; Durack DT
Clin Infect Dis; 1998 Dec; 27(6):1470-4. PubMed ID: 9868662
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE
Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
Martínez F; Martín Luengo F; Valdés M
Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Entenza JM; Caldelari I; Glauser MP; Moreillon P
J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
[TBL] [Abstract][Full Text] [Related]
9. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
Wilson WR; Zak O; Sande MA
J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
[TBL] [Abstract][Full Text] [Related]
10. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
Martínez F; Martín-Luengo F; Garcia A; Valdés M
J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
[TBL] [Abstract][Full Text] [Related]
11. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C
Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
[TBL] [Abstract][Full Text] [Related]
13. Treatment with various antibiotics of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
Martínez F; Martín-Luengo F; García A; Valdés M
Eur Heart J; 1995 May; 16(5):687-91. PubMed ID: 7588902
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.
Brennan RO; Durack DT
Antimicrob Agents Chemother; 1983 Feb; 23(2):273-7. PubMed ID: 6838188
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
16. Penicillin tolerance in experimental streptococcal endocarditis.
Pulliam L; Inokuchi S; Hadley WK; Mills J
Lancet; 1979 Nov; 2(8149):957. PubMed ID: 91047
[No Abstract] [Full Text] [Related]
17. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
Gavaldà J; López P; Martín T; Gomis X; Ramírez JL; Azuaje C; Almirante B; Pahissa A
Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
[TBL] [Abstract][Full Text] [Related]
19. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.
Blatter M; Fluckiger U; Entenza J; Glauser MP; Francioli P
Antimicrob Agents Chemother; 1993 Sep; 37(9):1971-6. PubMed ID: 8239615
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
